tiprankstipranks
Cellectar Biosciences (CLRB)
NASDAQ:CLRB
Holding CLRB?
Track your performance easily

Cellectar Biosciences (CLRB) Technical Analysis

1,269 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
6Bullish
2Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Cellectar Biosciences’s (CLRB) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting Cellectar Biosciences is a Buy.
Cellectar Biosciences’s (CLRB) 20-Day exponential moving average is 1.91, while Cellectar Biosciences’s (CLRB) share price is $1.57, making it a Sell.
Cellectar Biosciences’s (CLRB) 50-Day exponential moving average is 2.03, while Cellectar Biosciences’s (CLRB) share price is $1.57, making it a Sell.

Cellectar Biosciences (CLRB) Pivot Points

Nov 22, 2024, 07:43 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.37
1.46
1.51
1.60
1.65
1.74
1.79
Fibonacci
1.46
1.51
1.55
1.60
1.65
1.69
1.74
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cellectar Biosciences (CLRB) Moving Averages

Nov 22, 2024, 07:43 PM
Period
Simple
Exponential
MA5
1.68Sell
1.68Sell
MA10
1.89Sell
1.80Sell
MA20
1.97Sell
1.91Sell
MA50
2.04Sell
2.03Sell
MA100
2.13Sell
2.21Sell
MA200
2.74Sell
2.61Sell
Cellectar Biosciences’s (CLRB) 10-Day exponential moving average is 1.80, while Cellectar Biosciences’s (CLRB) share price is $1.57, making it a Sell.
Cellectar Biosciences’s (CLRB) 100-Day exponential moving average is 2.21, while Cellectar Biosciences’s (CLRB) share price is $1.57, making it a Sell.
Cellectar Biosciences’s (CLRB) stock price is $1.57 and Cellectar Biosciences’s (CLRB) 50-day simple moving average is 2.04, creating a Sell signal.
Cellectar Biosciences’s (CLRB) stock price is $1.57 and Cellectar Biosciences’s (CLRB) 100-day simple moving average is 2.13, creating a Sell signal.
Cellectar Biosciences’s (CLRB) stock price is $1.57 and Cellectar Biosciences’s (CLRB) 200-day simple moving average is 2.74, creating a Sell signal.

Cellectar Biosciences (CLRB) Technical Indicators

Nov 22, 2024, 07:43 PM
Name
Value
Implied Action
RSI (14)
21.39
Buy
STOCH (9,6)
10.85
Buy
STOCHRSI (14)
10.85
Buy
MACD (12,26)
-0.11
Buy
ADX (14)
23.21
Neutral
Williams %R
-76.07
Buy
CCI (14)
-216.01
Buy
ATR (14)
0.13
-
Ultimate Oscillator
38.95
Neutral
ROC
-22.17
Sell
Cellectar Biosciences’s (CLRB) Relative Strength Index (RSI) is 21.39, creating a Buy signal.
Cellectar Biosciences’s (CLRB) Trend Strength Indicator (ADX) is 23.21, creating a Neutral signal.
Cellectar Biosciences’s (CLRB) Commodity Channel Index (CCI) is -216.01, creating a Buy signal.
Cellectar Biosciences’s (CLRB) Price Rate of Change (ROC) is -22.17, creating a Sell signal.

FAQ

Is CLRB a Buy, Hold, or Sell?
Based on CLRB’s technical indicators, CLRB is a Sell.
    What is CLRB’s RSI (14)?
    CLRB’s RSI (14) is 21.39, which suggests CLRB is a Buy.
      What is CLRB’s MACD?
      CLRB’s MACD is -0.11, which suggests CLRB is a Buy.
        What is CLRB’s 5-day moving average?
        CLRB’s 5-day moving average is 1.68, which suggests CLRB is a Sell.
          What is CLRB’s 20-day moving average?
          CLRB 20-day moving average is 1.97, which suggests CLRB is a Sell.
            What is CLRB’s 50-day moving average?
            CLRB’s 50-day moving average is 2.04, which suggests CLRB is a Sell.
              What is CLRB’s 200-day moving average?
              CLRB’s 200-day moving average is 2.74, which suggests CLRB is a Sell.
                What is CLRB’s Williams % R (14)?
                CLRB’s Williams % R (14) is -76.07, which suggests CLRB is a Buy.
                  What is CLRB’s CCI (14)?
                  CLRB’s CCI (14) is -216.01, which suggests CLRB is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis